I have come to the conclusion that what this company needs is a large capital raising to fund it till the end of the year. Sure this would give rise to a significant dilution, but the price could then rise. We will have results from the cpN 10 trials and smoking cessation by then and time for analysis and reactions from the big pharma. We should then have a deal which would finance future development or else solid results which would allow new raising with much less dilution. These constant small issues under the Lind deal are killing us. I am not suggesting I am smarter than management. They probably know this and are doing their best. It is never easy to get these things right. As to valuation, 8 cents is a joke.
IVX Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)